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Abstract
Background: Intracellular transport of cargoes including organelles, vesicles, signalling molecules, protein complexes, and
RNAs, is essential for normal function of eukaryotic cells. The cytoplasmic dynein complex is an important motor that moves
cargos along microtubule tracks within the cell. In mammals this multiprotein complex includes dynein intermediate chains
1 and 2 which are encoded by two genes, Dync1i1 and Dync1i2. These proteins are involved in dynein cargo binding and
dynein complexes with different intermediate chains bind to specific cargoes, although the mechanisms to achieve this are
not known. The DYNC1I1 and DYNC1I2 proteins are translated from different splice isoforms, and specific forms of each
protein are essential for the function of different dynein complexes in neurons.
Methodology/Principal Findings: Here we have undertaken a systematic survey of the dynein intermediate chain splice
isoforms in mouse, basing our study on mRNA expression patterns in a range of tissues, and on bioinformatics analysis of
mouse, rat and human genomic and cDNA sequences. We found a complex pattern of alternative splicing of both dynein
intermediate chain genes, with maximum complexity in the embryonic and adult nervous system. We have found novel
transcripts, including some with orthologues in human and rat, and a new promoter and alternative non-coding exon 1 for
Dync1i2.
Conclusions/Significance: These data, including the cloned isoforms will be essential for understanding the role of
intermediate chains in the cytoplasmic dynein complex, particularly their role in cargo binding within individual tissues
including different brain regions.
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Introduction
To transport cargoes within eukaryotic cells, energy dependent
motors run along tracks in the cell formed by either the
microtubule network (dynein and kinesin motors) or the actin
cytoskeleton (used by myosin motors). The motor proteins
associated with microtubules can be classified as moving towards
the growing ‘plus’ end of microtubules (anterograde transport in
axons) or moving towards the ‘minus’ end of microtubules
(retrograde transport in axons). While several kinesin motors are
responsible for anterograde transport, the cytoplasmic dynein
complex is the single main retrograde transport motor.
Two cytoplasmic dynein complexes have been identified, of
which cytoplasmic dynein 1 is the most abundant in cells, while
cytoplasmic dynein 2 takes part in intraflagellar transport [1,2,3].
Cytoplasmic dynein 1 is a multisubunit complex of ,1.5 MDa; in
mammals this complex is thought to consist of a homodimer of
heavy chains (encoded by a single gene Dync1h1); two intermediate
chains (encoded by two genes Dync1i1, Dync1i2); light-intermediate
chains (encoded by two genes Dync1li1, Dync1li2); light chains
(thought to be encoded by three gene families, containing six
different genes (Dynlt1, Dynlt3, Dynlrb1, Dynlrb2, Dynll1, Dynll2))
[1,4,2,3]. The core of the dynein complex is a homodimer of the
heavy chains which binds to microtubules and enables cytoplasmic
dynein to move in an ATP dependent manner [5,6]. The other
dynein subunits are thought to associate in the complex as
homodimers and to maintain the stability of the complex, to
modulate its activity, and to interact with accessory and cargo
proteins [7,8,3,9].
The interaction and regulation of cytoplasmic dynein 1 with
its cargos is poorly understood; the intermediate chain proteins
DYNC1I1 (IC1) and DYNC1I2 (IC2) play roles in cargo binding
and are involved in cargo specificity [10,7]. It is also clear that
interactions of the dynein complex with cargoes often requires
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the presence of the dynactin complex – another large, multi-
subunit complex that binds to both the intermediate chains of
the dynein complex to modulate dynein-cargo interactions, and
to microtubules to modulate the movement of dynein [11,12].
However, IC1 and IC2 may also interact directly with protein
cargos including beta-catenin [13], casein kinase II [14],
neurofilaments [15], kinesin light chains 1 and 2 [16] and hunt-
ingtin [17].
IC1 and IC2 share 69% protein identity and have a molecular
weight of approximately 74 kDa [18,2,3], and can form homo- or
heterodimers in overexpression assays [19]. They interact with the
dynein light chains and the p150 subunit of dynactin at the N-
terminus and with the heavy chains through WD40 repeats at the
intermediate chain C-terminus [20,2,3]. Both proteins are
expressed in multiple splice isoforms – alternative splicing occurs
at their N-terminal regions and tissue- and development-specific
isoforms have been described in human, rat and mouse (for brief
discussion and original references see [21,22,23,3]. The functional
importance of individual splice isoforms is highlighted by the
discovery that in rat one dynein complex containing a IC1
isoform, specifically binds nerve growth factor receptor TrkB-
containing endosomes in neurons [10], thus this isoform likely
confers cargo specificity on the dynein complex and is important
for neuronal function. Conversely, dynein complexes containing
IC2 are important for transport of TrkA signalling endosomes in
PC12 cells [10].
Since this evidence indicates that alternatively spliced interme-
diate chain isoforms are central to dynein complex function and
cargo specificity, we undertook a survey of their expression in a
range of mouse tissues, using both RNA studies and bioinformatics
analysis including comparison with human and rat data. Here we
show (1) new splice isoforms for both genes, (2) a systematic survey
of expression of different intermediate chain splice isoforms in a
range of adult and embryonic mouse tissues, including different
brain regions and spinal cord, (3) and we also identify transcription
of Dync1i2 from a new upstream promoter that results in an
alternative non-coding exon 1 and a second set of Dync1i2
transcripts.
This survey serves as the basis for a thorough functional
dissection of the dynein intermediate chains in mouse and their
likely roles in binding different cargoes in a cell-specific and
development-specific manner, particularly within the nervous
system.
Results
To determine the splice isoform patterns of the mouse dynein
intermediate chain 1 and 2 genes, we used a combination of
reverse-transcription polymerase chain reactions (RT-PCRs) of
mouse RNA, literature searching and bioinformatics analysis of
mouse (version mm9), rat (rn4) and human (hg19) data in the
UCSC Genome Browser. We note that because different
nomenclatures have already been applied to the few previously
described mouse and rat dynein intermediate chain isoforms
(Table 1), for clarity we base our nomenclature on that of Pfister,
Vaughan, Vallee, and colleagues who described three rat protein
isoforms of DYNC1I1 (IC1A, 1B, 1C) and three isoforms of
DYNC1I2 (IC2A, 2B, 2C) [21,22,23]. In line with current gene
nomenclature rules, we also include a UCSC or Ensembl accession
number relating to a ‘reference’ cDNA sequence for each isoform
described below.
Analysis of the splicing pattern of mouse Dync1i1
Dync1i1 is located on chromosome 6 band qA1, spanning over
302,000kb between base pairs 5,675,739 and 5,978,030 (Ensembl,
March 2010, transcript ENSMUST00000115555), and exons 1
and exon 17 contain the 59UTR and 39UTR respectively; the start
methionine is encoded in exon 2 (the exon-intron boundaries of
the mouse genomic locus are given in Table S1). We found no
evidence for alternative first or last exons. A conserved miRNA
binding site for miR155 lies in the 39UTR as determined by
TargetScan.
To survey theDync1i1 splicing pattern spatially and temporally in
mouse, we extracted total RNA from a set of tissues: adult male and
female: brain, spinal cord, ovary, testis, spleen, lung, kidney, heart,
intestine, muscle, liver; and embryonic E17.5: whole embryos,
Table 1. Mouse dynein intermediate chain splice isoforms.
Mouse dynein intermediate chain 1 (Dync1i1)
Mouse
isoform
name
GenBank
accession
number
UCSC and/or ENSEMBL
accession number for ‘reference
sequence’ for each isoform
Homologous published rat isoforms
[21,22] and previously described
mouse isoforms, in italics [34] Exons
Exon 4 alter-
native splice
site
Number
of amino
acids
Dync1i1.A ENSMUST00000115555 IC 1A
Dnci1a
1 to 17 AS1 645
Dync1i1.B NM_010063.3 uc009awn.1, ENSMUST00000115559 IC 1B
Dnci1c
1 to 17 AS2 628
Dync1i1.D ENSMUST00000115556 Dnci1d 1 to 17 AS3 617
Dync1i1.E GU992206* 1 to 4, 6 to 17 AS1 625
Dync1i1.C ENSMUST00000115554 IC 1C
Dnci1e
1 to 4, 6 to 17 AS2 608
Dync1i1.F GU992207* 1 to 4, 6 to 17 AS3 597
The mouse gene nomenclature convention is to name each isoform: genename_GenBank transcript number. We have used the unofficial names Dync1i1.A, Dync1i1.B,
etc., here to show their correspondence to the widely used IC 1A, 1B, 1C previously described in rat [22]. However, we also show the correspondence to GenBank mouse
cDNAs, UCSC known genes and Ensembl transcripts. As Dync1i2 has two alternative non-coding first exons, we cannot determine which Dync1i2 isoforms correspond to
the previously described rat isoforms IC2A, 2B, 2C, hence these are in parentheses [22]. Crackower and colleagues noted the presence of some mouse splice isoforms
and we also show to their notation from their 1999 publication Dnci1a, c, d, e in italics [34]. We number exons from 1 to 17 for Dync1i1, and from 1 to 18 for Dync1i2
including either exon 1a or exon 1b, and exon 3b.
*first described in this paper.
doi:10.1371/journal.pone.0011682.t001
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brain and spinal cord. We synthesised cDNA from oligo dT primers
and then amplified PCR products using the primers DIC1_Ex 1 for
and DIC1_Ex 17 rev (Table 2) that bind within the first and last
exons of the longest mouse Dync1i1 sequence in the UCSC
database, uc009awn.1 (RefSeq sequence NM_010063.3).
We found a complex pattern of amplified fragments in brain,
spinal cord, and the embryonic tissues, one homogenously sized
amplicon in testis and ovary, and no amplification detectable from
spleen, lung, kidney, heart, intestine, muscle or liver. PCR
products were sequenced and the amplicon in testis and ovary
was found to be a single transcript, here named isoform Dync1i1.C
(Figure 1). The sequences from the adult brain, spinal cord, and
E17.5 embryonic tissues were unreadable, presumably due to the
presence of multiple splice isoforms. To further investigate, the
PCR products from brain and spinal cord were subcloned and
sequenced to determine which exons were present in individual
transcripts.
From sequencing 62 brain and 14 spinal cord subclones and
from a bioinformatics analysis of mouse, human and rat, we found
six different transcripts, including two novel isoform (here named
Dync1i1.E and Dync1i1.F) (Figure 1). Exon 5 (60 bp) is absent
from three of these transcripts (1.C, 1.E, 1.F). We also found, that
exon 4 has three possible alternative splice sites, in agreement with
human bioinformatics, while only two splice sites were detected
experimentally in rat.
To determine which individual isoforms were present in
dissected brain regions (cortex, cerebellum, brain stem, hippo-
campus, olfactory bulb) and other tissues we designed a panel of
isoform specific primer pairs (Table 2) and surveyed tissues for the
presence or absence of the six Dync1i1 isoforms (for example,
Figures 2, S1). We found our amplification results showed
reproducible differences in the patterns of intensity of individual
amplicons in different tissues; for example, compare amplification
of brainstem and olfactory bulb in Figure 2B. Although RT-PCR
is not a quantitative method these robust and repeatable
amplification patterns probably indicate differences in relative
expression of the isoforms in different brain regions. We went on
to use nested PCRs to confirm the presence of some individual
amplicons which had similar lengths for initial PCRs (for example,
Figures 3, S2). A summary of our findings is presented in
Table 3 and Figure 1. In addition we note that for isoform:
Dync1i1.A. This isoform was detected originally at low levels
in adult brain by RT-PCR and was then cloned and sequenced.
This isoform corresponds to the previously described protein,
DYNC1I-1A (IC1A) in rat [6,2,3]. We confirmed the presence of
this isoform in a specific RT-PCR using primers DIC1_1.1 for and
DIC1_5 rev to detect a 206 bp amplicon in multiple brain regions
and spinal cord, and embryonic tissues but not other tissues in
mouse (Figure 3, Table 3). Database searches showed
orthologous isoforms in human (uc003uoc.3) and rat
(NM_019234.1).
Dync1i1.B. This isoform was detected in 33/62 subclones
from adult mouse brain and 9/14 subclones from adult mouse
spinal cord. It is identical to the mouse cDNA uc009awn.1 and
corresponds to the previously described protein, IC1B in rat
[21,23]. Dync1i1.B is expressed in the nervous system and
embryonic tissues only (Table 3). Database searches found an
orthologous full-length cDNA in human (uc003uod.3), but only
ESTs in rat (CB703089, CB747457).
Dync1i1.D. This isoform was detected in 16/62 subclones
from adult mouse brain and 5/14 subclones from adult mouse
spinal cord, and was amplified in these tissues and embryonic
tissues using two different sets of primer pairs (DIC1_Ex 1for and
DIC1_R rev, DIC1_Ex 1 for and DIC1_5 rev, Table 2) but did
not amplify in other tissues. This isoform has been found as a
human EST (DA392898) but is not present in the current rat
databases.
Dync1i1.E. This novel isoform has not been characterized
previously. It was not detected during the initial cloning analysis
nor was it present amongst the UCSC mouse sequences (mm9).
However, by database searching we found a human cDNA
(uc003uoe.3) and a rat EST (CB712052) in which AS1 in exon 4 is
present and exon 5 is removed. Therefore we designed PCR
primers (DIC1_1.1 for and DIC1_iso14 rev) to detect only this
isoform in mouse. In all brain tissues examined plus spinal cord
and embryonic tissues, the expected 155 bp product was amplified
(for example see Figure S2). This isoform was not found outside
of brain or spinal cord, or embryonic tissues. The GenBank
accession number obtained for this sequence is GU992206
(Table 1).
Dync1i1.C. This isoform was detected in 12/62 subclones
from adult mouse brain and unlike the other Dync1i1 transcripts it
was found in ovary and testis, but not other tissues (in
amplification with the primer pairs DIC1_Ex 1 for and DIC1_R
rev or DIC1_Ex 1 for and DIC1_iso14 rev) (Figure S1). It
corresponds to the previously described protein IC 1C in rat. This
isoform has a human full-length orthologue, uc003uob.2, and is
homologous to two rat ESTs CB616735, CB713291.
Dync1i1.F. This novel isoform was detected in 1/62
subclones from brain, and amplified at low levels throughout the
nervous system and embryonic tissues, with primer pairs DIC1_Ex
1 for and DIC1_R rev, and DIC1_Ex 1 for and DIC1_iso14 rev,
but it does not amplify in other tissues. We did not find
orthologous human or rat sequences in the databases. This is a
low abundance isoform in the tissues assayed and it remains
unknown if it is a functional transcript. The GenBank accession
number obtained for this sequence is GU992207 (Table 1).
Analysis of the splicing pattern of mouse Dync1i2
Dync1i2 maps to chromosome 2, band C2, spanning over
51,000kb between base pairs 71,049,798 and 71,101,360 (En-
sembl, March 2010, transcript ENSMUST00000112140). The
start methionine lies in exon 2. We did not detect any evidence for
Table 2. Primer pairs used to amplify individual Dync1i1
splice isoforms (Figure 1).
Primer pair
Isoform
detected
Predicted size of
amplicon
DIC1_Ex 1 for and DIC1_R rev Dync1i1.A
Dync1i1.B
Dync1i1.D
Dync1i1.E
Dync1i1.C
Dync1i1.F
531 bp
480 bp
447 bp
471 bp
420 bp
387 bp
DIC1_Ex 1 for and DIC1_AS4 rev Dync1i1.A
Dync1i1.B
371 bp
320 bp
DIC1_Ex 1 for and DIC1_5 rev Dync1i1.A
Dync1i1.B
Dync1i1.D
477 bp
426 bp
393 bp
DIC1_Ex 1 for and DIC1_iso14 rev Dync1i1.E
Dync1i1.C
Dync1i1.F
447 bp
396 bp
363 bp
DIC1_1.1 for and DIC1_5 rev Dync1i1.A 206 bp
DIC1_1.1 for and DIC1_iso14 rev Dync1i1.E 155 bp
doi:10.1371/journal.pone.0011682.t002
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PLoS ONE | www.plosone.org 3 July 2010 | Volume 5 | Issue 7 | e11682
microRNA binding sites in the 39UTR of the gene (the
exon-intron boundaries of the mouse genomic locus are given in
Table S1).
Bioinformatics analysis of the Dync1i2 gene in mouse, human
and rat showed that in all three species this gene produces two sets
of transcripts containing different first exons, indicating the
presence of two independent promoters; this is corroborated by
analysis with the DBTSS track of the UCSC Genome Browser
which distinguishes two active promoters, adjacent to two non-
coding exons in the three species. We named the two alternative
exons 1a and 1b. Exon 1a is upstream of Exon1b and they are
separated by ,125bp of genomic DNA with no overlap between
the exons. We found no transcript that contained both exons. We
note that the start methionine remains the same in all Dync1i2
transcripts as this lies in exon 2.
To survey Dync1i2 splicing we designed two RT-PCRs based on
sequences in the UCSC Genome Browser (exon 1a: uc008kah.1,
uc008kai.1; exon 1b: uc008kak.1, uc008kaj.1). We amplified
sequence using forward primers from either exon 1a (DIC2_Ex1a
for) or exon 1b (DIC2_Ex1b for) and one reverse primer lying in
the last exon of the gene (DIC2_Ex18 rev) (Primer sequences used
to determine the splicing patterns of Dync1i1 and Dync1i2 are given
in Table S2). Amplified products of Dync1i2 from both primer
pairs were purified and sequenced.
In all non-neuronal and non-embryonic tissues, we found that
primers specific for either exon 1a or exon1b yielded a single
isoform designated 2C in this paper i.e. Dync1i2(1a).C or
Dync1i2(1b).C (Figure 4). However, the amplification patterns in
the nervous system and embryonic tissues were complex and we
were unable to sequence the mix of PCR products from these
tissues. To determine which isoforms of Dync1i2 were expressed in
these tissues, the RT-PCR products were subcloned and
sequenced; subsequent analysis, revealed a total of 11 different
isoforms each having either exon 1a or exon 1b at the start of the
transcript (Table 1, Figure 4). This Includes two novel isoforms
(Dync1i2(1a).D and Dync1i2(1b).D, Figure 4) that were detected
during RT-PCR analysis.
Based on the information from individual subclones derived
from both exons 1a and 1b, we then designed isoform specific
primer pairs to survey all mouse tissues previously described; we
used nested PCRs to confirm the presence of some individual
amplicons whch had similar lengths in our intial PCRs (Table 4,
Figure 5, 6).
We also detected a novel exon of 51bp, here designated exon
3b, which lies downstream of exon 3; this has two alternative splice
sites (Figure 4). Exon 3b does not align to human genomic
sequence from either dynein intermediate chain gene but does
appear to have an equivalent sequence in rat genomic DNA in
Dync1i2. In mouse, when we align exon 3b with Dync1i1 genomic
sequence, aligning either DNA or the translations, we are unable
to detect a likely equivalent exon, thus this exon 3b appears
specific for Dync1i2 in mouse and rat (and see Discussion).
Summary of mouse Dync1i2 alternative splicing
A summary of our findings is presented in Table 5, Figure 4.
We found Dync1i2 has 11 isoforms: six including exon 1a, five
including exon 1b; isoforms with the same exon content other than
exon 1a and 1b have similar but not identical expression patterns
(Table 5). In addition we note that for isoform:
Dync1i2(1b).D. This novel isoform was identified as an
unexpected larger 340 bp product that was produced in addition
to the expected Dync1i2(1b).E (325 bp) amplicon when some but
not all nervous system tissues were amplified with the primers
DIC2_Ex 1b for and DIC2_2.1 rev. The fragment was sequenced
and found to contain the new exon, 3b, which is flanked by
consensus splice sites and has two alternative splice acceptor sites.
We did not find an alignment of exon 3b in the human genomic
dynein intermediate chain genes. However, in rat, while no
equivalent transcripts are in the databases, we did detected a
48 bp almost perfect alignment to rat genomic sequence in the
expected position within rat intron 3, except that an internal 3bp
(GAG, encoding glutamic acid), is absent. The complete 48 bp can
be transcribed into a 16 amino acid peptide that maintains the
open reading frame of the protein and thus this is likely to be rat
exon 3b. Dync1i2.D is the longest Dync1i2(1b) transcript we can
detect, being 2,478 bp in length. This isoform does not so far have
orthologs in human or rat. GenBank accession number obtained
for this sequence is GU992211 (Table 1).
Dync1i2(1a).D. This novel isoform was amplified using
primers spanning Exon 1a and exon DIC2_Ex 1a for and
Figure 1. Splicing pattern of mouse dynein intermediate chain 1 gene. A. Summary of alternative splicing in Dync1i1, showing splice
variants Dync1i1.A to Dync1i1.F, and the first 6 exons (numbered 1, 2, 3, 4, 5, 6); primer binding sites used for isoform specific RT-PCRs are as indicated
(Table 2, S2), and AS1, 2 and 3 are the alternative splice sites in exon 4. Exons are drawn to scale. B. Alternative splice sites in Dync1i1 exon 4. The
nucleotide in bold is the first base pair of the exon. Bases in lower case are intronic, bases in upper case are exonic.
doi:10.1371/journal.pone.0011682.g001
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DIC2_2.1 rev to determine if an equivalent to Dync1i2 Exon 1b.D
was expressed. The isoform was found in some but not all nervous
system tissues, and in embryonic nervous system but not whole
embryo. It is the longest Dync1i2(1a) transcript we can detect,
being 2,493 bp in length. This isoform does not so far have
orthologs in human or rat. The GenBank accession number
obtained for this sequence is GU992208 (Table 1).
Dync1i2(1a).E. This novel isoform was detected based on the
sequence of Dync1i2(1b).E, in all nervous system tissues except for
olfactory bulb, and embryonic tissues, using PCR with primers
DIC2_Ex 1a for and DIC2_6 rev and then nested PCR with
DIC2_Ex 1a for and DIC2_2.1 rev and sequencing of the
amplified 300 bp product. This isoform does not so far have
orthologs in human or rat and we note that Dync1i2(1b).E is a low
abundance transcript. The GenBank accession number obtained
for this sequence is GU992209 (Table 1).
Dync1i2(1b).E. This novel isoform was found as one clone
out of 64 in brain; it has not been detected so far in human
transcripts and it may be a low abundance transcript that is
specific to the mouse/rat evolutionary branch. The GenBank
accession number obtained for this sequence is GU992212
(Table 1).
Figure 2. Amplification of different isoforms of Dync1i1 in mouse tissues using one primer pair. Isoforms of Dync1i1 were amplified in
mouse tissues using primer pair DIC1 Ex1 for and DIC1_R rev which produces six products: Dync1i1.A (531 bp), Dync1i1.B (480 bp), Dync1i1.E (471 bp),
Dync1i1.D (447 bp), Dync1i1.C (420 bp), Dync1i1.F (387bp). Dync1i1.B (480 bp) and Dync1i1.E (471 bp) are not resolved due to similar length of PCR
products, and were subsequently individually confirmed as present using isoform specific primer pairs (Table 2), for example see amplification of
Dync1i1.E using isoform specific primer pair DIC1_1.1 for and DIC1_5 rev (Figure S2). Note that in some tissues amplification products are faint, and
so results were confirmed with other primer pairs as indicated in Table 2; for example, see amplification of Dync1i1.A in Figure 3. In some tissues we
also saw a high molecular weight fragment running at approximately 560bp (for example see spinal cord or cerebellum); this may represent another
isoform but we were unable to clone or sequence this fragment. A. Adult tissues: brain, ovary, testis and liver. In brain 6 amplicons are detected as
shown. In ovary and testis we detect isoform Dync1i1.C only (420bp). No product is amplified in liver. B. Adult neuronal tissues: in spinal cord, cortex,
hippocampus, cerebellum, brainstem and olfactory bulb, between four and six amplicons (for example compare brainstem and olfactory bulb) could
be detected as shown. C. Embryonic tissues: five amplicons are detected as shown. ‘+’ lanes are cDNA, ‘2’ lanes control for genomic DNA
contamination and have no reverse transcriptase.
doi:10.1371/journal.pone.0011682.g002
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Dync1i2(1a).A. This isoform was detected in 36/75 brain
subclones and 8/82 spinal cord subclones. It corresponds to mouse
cDNA ENSMUST00000112140 and has an homologous full-
length human cDNA sequence uc002uha.1 and is also described
by a rat EST CB784025. It is detected by RT-PCR with the
primer pairs DIC2_Ex 1a for and DIC2_R rev, DIC2_Ex 1a for
and DIC2_N4 rev, and DIC2_Ex 1a for and DIC2_6 rev
(Table 4).
Dync1i2(1b).A. This isoform was detected in 35/64 brain
subclones and 17/72 spinal cord subclones; it corresponds to the
human cDNA uc002uhe.1 and rat cDNAs RefSeq NM_053880,
and GenBank mRNA U39044. It is amplified by the primer pairs
DIC2_Ex 1b for and DIC2_R rev, DIC2_Ex 1b for and
DIC2_N4 rev and DIC2_Ex 1b for and DIC2_6 rev.
Dync1i2(1a).B. This isoform was detected in 16/75 brain
subclones and 17/82 spinal cord subclones. It is shorter than
isoform Dync1i2(1a).A by 18 bp as a result of removing of exon 4.
This isoform is described by a number of human ESTs
(BP228682, BP229314, DA386957, DA488835, DA492636,
DA497525, DA694727, DA696722, DA749926, DA769782,
DA776852, DB003699, DB038590, DA493266, DA487646,
DB173651) and rat EST CF977964. It is detected by primer
pairs DIC2_Ex 1a for and DIC2_R rev and DIC2_Ex 1a for and
DIC2_6 rev.
Dync1i2(1b).B. This isoform was detected in 15/64 brain
subclones and 23/72 spinal cord subclones. It is shorter than
isoform Dync1i2(1b).A by 18 bp as a result of removing of exon 4
and it corresponds to human full-length cDNA uc002uhd.1 and
rat GenBank mRNA U39045, ESTs CB711834, CK470011,
CV107841 and in mouse is detected by primer pairs DIC2_Ex 1b
for and DIC2_R rev, and DIC2_Ex 1b for and DIC2_6 rev.
Dync1i2(1a).F. This novel isoform was detected in 1/75
brain subclones, in mouse only – no corresponding human or rat
expressed sequences have been found so far, thus this may be a low
abundance isoform or an aberrant splice product without
functional significance. This isoform should be detected in
mouse with primer pairs DIC2_Ex 1a for and DIC2_R rev,
DIC2_Ex 1a for and DIC2_N4 rev and DIC2_Ex 1a for and
DIC2_iso24 rev, however we were not able to detect it in any
tissue by PCR. The GenBank accession number obtained for this
sequence is GU992210.
Putative Dync1i2(1b).F. We are unable to determine if this
exists. We tried several times in each tissue to detect the presence
of isoform Dync1i2(1b).F but were consistently unable to do so.
We cannot detect it by RT-PCR or in any of our subclones, nor is
it present in the current human or rat transcript databases. This
may show this isoform is not expressed. However, we note that
the Dync1i2 Exon 1a.F equivalent is also detected at low
abundance.
Dync1i2(1a).C. This isoform was detected in 19/75 brain
subclones and 53/82 spinal cord subclones and all other tissues, it
corresponds to human cDNA uc002uhb.1 and rat ESTs
CK365527, EV774963, FM056664. It is detected in mouse with
primer pairs DIC2_Ex 1a for and DIC2_R rev, and DIC2_Ex 1a
for and DIC2_iso24 rev.
Dync1i2(1b).C. This isoform was detected in 13/64 brain
subclones and 36/72 spinal cord subclones, and all other tissues, it
corresponds to human uc002uhf.1 and rat GenBank mRNA
U39046 and ESTs CD568113, CK355960, CK367553,
CK471588, CV108862, EV763033, EV774374. It is detected
using mouse primers DIC2_Ex 1b for and DIC2_R rev, and
DIC2_Ex 1b for and DIC2_iso24 rev.
Table 3. Summary of mouse dynein intermediate gene 1 splice isoform expression in different mouse tissues.
Dync1i1
Tissue Dync1i1.A Dync1i1.B Dync1i1.D Dync1i1.E Dync1i1.C Dync1i1.F
Whole adult brain + + + + + +
Adult spinal cord + + + + + +
Adult cortex + + + + + +
Adult cerebellum + + + + + +
Adult brainstem + + + + + +
Adult hippocampus + + + + + +
Adult olfactory bulb + + + + + +
Whole embryo E17.5 + + + + + *
Embryonic brain E17.5 + + + + + +
Embryonic spinal cord E17.5 + + + + + *
Ovary +
Testis +
Spleen
Kidney
Lung
Heart
Intestine
Muscle
Liver
No differences were detected in male and female samples, thus results are not broken down by sex.
*weak amplification detected.
doi:10.1371/journal.pone.0011682.t003
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Figure 3. An isoform specific RT-PCR: screening for Dync1i1.A in mouse tissues. Primers DIC1_1.1 for and DIC1_5 rev amplify a 206 bp
product from isoform Dync1i1.A. ‘+’ lanes are cDNA, ‘2’ lanes control for genomic DNA contamination and have no reverse transcriptase. Dync1i1.A is
found in all brain regions screened, but may not be highly expressed in the E17.5 whole embryo, although this is not a quantitative PCR (data not
shown).
doi:10.1371/journal.pone.0011682.g003
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Discussion
We undertook an extensive survey of the expression of mRNAs
of the cytoplasmic dynein intermediate chain genes Dync1i1 and
Dync1i2 in a range of mouse tissues. We utilized RT-PCR on
mouse transcripts to show the presence of new intermediate chain
isoforms in the mouse including those derived from novel exons
and non-coding exons. We found the greatest complexity to be
present in the adult nervous system. Bioinformatic analyses
corroborate the existence of these complex splicing patterns and
new isoforms and confirm the similarities between mouse, human
and rat. These analyses were performed at the tissue, not cellular,
level and other less abundant isoforms may remain to be
identified, particularly those expressed earlier in development
than E17.5. For example, we detected at a low level from mouse,
cDNAs of Dync1i2 isoforms that are deleted for a single glutamine
residue in exon 18 (data not shown, Ensembl transcripts
ENSMUST00000112136, ENSMUST00000112139), and we find
the presence of two other possible new isoforms present as full-
length cDNAs in human (uc010zdt.1 (exon 1a), uc010zds.1 (exon
1b), hg19, GRCh37), however, these do not appear to be
expressed in mouse or rat (A.Kuta, unpublished). These transcripts
contain an exon 5 which is 54 bp longer than the exon 5 shown
here because of the use of an upstream alternative 39 splice site;
and at the same time exons 4 and 6 are excluded, which results in
a protein of 630 amino acids in length.
Prior to this work, the distribution and expression of
intermediate chain splice isoforms had been best studied in the
rat [21,22,23,24]. However, dynein intermediate chain splice
isoforms are not restricted to mammals or vertebrates. For
example, complex splicing patterns are found in the homologous
intermediate chain gene in Drosophila, Cdic [25] and these patterns
arise from alternative splicing of three small exons located between
exons 4 and 5 of this gene. This strongly suggests that alternative
splicing of the N-terminal region of the intermediate chains is
essential for some aspect of eukaryotic dynein motor protein
function in cells.
Alternative 59 non coding exons in Dync1i2
The presence of two alternative 59 non-coding first exons in
Dync1i2 is intriguing and suggests another complex layer of
regulation. We detected differences in the relative expression levels
of Dync1i2 isoforms depending on whether exon 1a or 1b was
spliced into the transcript (Table 5); for example see the
expression of Dync1i2(1a).E and 2(1b).E in adult brain and whole
embryo (Figure 7). As the human and mouse genomes are
analyzed an increasing number of genes are found to have
alternative non-coding first exons [26]. Recent studies in human
have found approximately 50% of genes have at least one
alternative promoter and such genes tend to have significantly
longer genomic structures including 59 and 39 UTRs, intron and
exon lengths and numbers of exons compared to genes with single
promoters ([27] and references therein). Interestingly Dync1i1 is a
significantly longer gene than Dync1i2, but so far we can find no
evidence for it having an alternative non-coding 59 exon. The use
of alternative promoters is thought to be associated with cell-
specific expression; for example the human CYP19 aromatase
gene has at least 10 alternative non-coding first exons [28] which
appear to control mRNA stability and gene expression [29].
Figure 4. Splicing pattern of mouse dynein intermediate chain 2 gene. A, B. Summary of alternative splicing in Dync1i2 with exon 1a or 1b
respectively and the first seven exons (numbered 1a or 1b, 2, 3, 3b, 4, 5, 6, 7). Primer binding sites used for isoform specific RT-PCRs are as indicated
(Table 4, S2). AS refers to alternative splice sites in exon 3b. Note that we could not detect the presence of the putative Dync1i2(1b).F in any tissue
surveyed. Exons are drawn to scale. C. Alternative splice sites in Dync1i2 exon 3b. The nucleotide in bold is the first base pair of the exon. Bases in
lower case are intronic, bases in upper case are exonic.
doi:10.1371/journal.pone.0011682.g004
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Similarly, the use of three (in mouse and human) or two (in rat)
alternative promoters resulting in the expression of alternative
non-coding first exons has been shown for GATA4 gene [30].
Significance of the different intermediate chain isoforms
We have shown that different tissues express different
intermediate chain isoforms. All of the Dync1i1 isoforms were
found only in nervous tissue, with the exception of Dync1i1.C,
which was also found in ovary and testis. This result is consistent
with previous studies in rat that found that all the IC1 isoforms are
expressed exclusively in the nervous system, except that one was
found in testis, and ovary was not examined, [21,22,23]. We
further found that most mouse tissues express only the IC2C
isoforms; this is different from rat, where most tissues express both
IC2C and IC2B [21,22,23].
While our RT-PCR results are not quantitative, there are
clearly reproducible differences between tissues, and our studies
further indicate the isoforms also expressed at different levels in
different tissues. Further, preliminary data using fluorescent
primers and capillary gel electrophoresis to determine the relative
amounts of each amplicon in the total amplified pool, showed
tissue specific differences in expression (Kuta, A. unpublished).
The patterns we see consistently show that when RT-PCR results
for Dync1i1 and Dync1i2 isoforms are compared between different
brain regions the relative proportions of the different isoforms are
different (for example, see Figures 2, 5).
Most of the splice isoform complexity we observed for both
intermediate chains is within the nervous system tissue. This is
consistent with the previously published data from rat where all six
identified intermediate chain isoform were expressed in the adult
brain. In rat, the analysis of the expression of the isoforms was
extended to the cellular level and these data demonstrated that the
basis for the complexity was in the neurons. Cultured embryonic
cortical and hippocampal neurons expressed the IC1B, 1C, 2B,
and 2C isoforms. All other cultured cells, including glia, expressed
only the IC2C isoform, except that IC2B was found in
neuroblastomas [22,23,31].
The cytoplasmic dynein complex is involved in many processes
including protein and RNA transport, organelle trafficking, as well
as mitosis, endosome sorting, and the cellular stress response and
response to hypoxia. The neuronal intermediate chain complexity
may reflect the dependence of axonal and cellular survival on the
efficient transport of trophic and other factors from the synapse to
the cell body (often over 1m in length) [32,11,33]. It also may
reflect the complexity of the different types of cargoes that have to
be actively transported within neurons, both in the adult and in the
developing embryo. Axonal transport must be a highly regulated
and ordered process to transport such disparate organelles and
cargo. While the precise role of the intermediate chains in dynein
regulation in these processes is not completely understood, it is
known that dynein complexes with specific intermediate chains are
responsible for the transport of individual organelles. For example
dynein complexes with IC1B, are necessary for the transport of
Trk signalling endosomes in rat hippocampal axons [10,21,22,23].
At the minimum, the intermediate chain isoforms produce
functionally distinct classes of dynein complexes that may be
separately regulated to carry different specific cargoes.
Consistent with a role for the intermediate chains in neuron
specific function, we clearly observed differences in the expression
of intermediate chain isoforms when the patterns from late
embryonic and adult brain are compared. In rat only the generic
IC2C was found at E13, but with increasing embryonic age, first
IC2B and then IC1B and 1C were found. While the IC2A and 1A
isoforms were found only in the adult (P20 and older) [23]. Using
probes for specific for common regions of IC1 and IC2,
Crackower and colleagues investigated dynein intermediate chain
expression in mouse embryos at different stages of development
using whole mount in situ hybridization. They found that at mouse
E10.5–13.5 Dync1i1 was restricted to the developing cortex and the
peripheral nervous system (dorsal root ganglia and sympathetic
ganglia), while Dync1i2 was more widely expressed within the
nervous system [34]. In addition Dync1i2 was found to be highly
expressed a non neuronal tissue, the mouse developing limb bud
[34], and may play a role in establishing cell polarity by
orientating intracellular components correctly [35,3].
Relationship between exons and protein domains for
dynein intermediate chains
The intermediate chains have a scaffold-like role in the dynein
complex. They dimerize and bind to the dynein heavy chain, the
three light chain dimers, and the putative cargo adaptor,
dynactin. The intermediate chains and the light chains, with
Table 4. Primer pairs used to amplify individual Dync1i2
splice isoforms (Figure 4).
Dync1i2 exon1a splice isoforms
Primer pair
Isoform
detected
Predicted
bands
DIC2_Ex 1a for and DIC2_R rev Dync1i2(1a).D
Dync1i2(1a).E
Dync1i2(1a).A
Dync1i2(1a).B
(Dync1i2(1a).F)
Dync1i2(1a).C
556 bp
541 bp
505 bp
487 bp
445 bp
427 bp
DIC2_Ex 1a for and DIC2_2.1 rev Dync1i2(1a).D
Dync1i2(1a).E
315 bp
300 bp
DIC2_Ex 1a for and DIC2_N4 rev Dync1i2(1a).D
Dync1i2(1a).E
Dync1i2(1a).A
(Dync1i2(1a).F)
352 bp
337 bp
301 bp
301 bp
DIC2_Ex 1a for and DIC2_6 rev Dync1i2(1a).D
Dync1i2(1a).E
Dync1i2(1a).A
Dync1i2(1a).B
496 bp
481 bp
445 bp
427 bp
DIC2_Ex 1a for and DIC2_iso24 rev (Dync1i2(1a).F)
Dync1i2(1a).C
405 bp
387 bp
Dync1i2 exon1b splice isoforms
DIC2_Ex 1b for and DIC2_R rev Dync1i2(1b).D
Dync1i2(1b).E
Dync1i2(1b).A
Dync1i2(1b).B
(Dync1i2(1b).F)
Dync1i2(1b).C
581 bp
566 bp
531 bp
513 bp
(471 bp)
453 bp
DIC2_Ex 1b for and DIC2_2.1 rev Dync1i2(1b).D
Dync1i2(1b).E
340 bp
325 bp
DIC2_Ex 1b for and DIC2_N4 rev Dync1i2(1b).D
Dync1i2(1b).E
Dync1i2(1b).A
(Dync1i2(1b).F)
378 bp
363 bp
(327 bp)
DIC2_Ex 1b for and DIC2_6 rev Dync1i2(1b).D
Dync1i2(1b).E
Dync1i2(1b).A
Dync1i2(1b).B
522 bp
507 bp
471 bp
453 bp
DIC2_Ex 1b for and DIC2_iso24 rev (Dync1i2(1b).F)
Dync1i2(1b).C
(431 bp)
413 bp
Note that we have been unable to detect the Dync1i2 exon 1b.F.
doi:10.1371/journal.pone.0011682.t004
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the light intermediate chains, form the cargo binding domain of
the cytoplasmic dynein complex [3,36,37]. The intermediate
chain N-terminal region forms a coiled-coil which interacts with
p150 subunit of dynactin [24]. At the C-terminal lies seven
WD40 repeats which are thought to form a b propeller structure
responsible for interaction with the dynein heavy chain [20,38].
Proximal to the WD repeats are the binding sites for the dynein
light chains and the dimerisation domain [19,8,39,40,41]. As can
be seen in Figure 8, (the position of domains in the longest
DYNC1I1 and DYNC1I2 isoforms are shown in Table S3) the
exon structure for these major functional domains is similar
between the IC1 and IC2 proteins. The alternative splice
isoforms of IC1 and IC2 affect the region of the protein
downstream of the N-terminal coiled coli region and upstream of
the region binding to DYNLT and DYNLL light chains, between
exons 3b/4 and exon 5. This region of the N-terminus has been
implicated in binding of the p150 subunit of dynactin, and it is
rich in serines and threonines, leading to suggestions that one
function of the alternative splicing is to generate novel
phosphorylation sites that are important for specific dynein
regulation, for example in modifying binding to the p150 subunit
of dynactin, or other putative cargo adaptors [24,42]. Our
observation that there is only 8.7% identity between IC1 exon 4*
(the fragment of exon 4 spanning between the start of this exon and
the AS2 site) and IC2 exons 3B and 4 compared to greater than
51% identity for other exons (Figure 8D) shows that this region is
one of significant variability between the intermediate chains and it
is consistent with the hypothesis that this region of the intermediate
chains may have an important role in dynein regulation.
Conclusion
The mechanisms of how dynein intermediate chains contribute
to the specificity of dynein function and its regulation are poorly
understood. To better understand intermediate chain variation,
we have characterized in detail the alternative splicing of the two
cytoplasmic dynein intermediate chains genes in the mouse. We
have identified new splicing patterns, a novel exon, and the
presence of two distinct first exons in Dync1i2. Mouse genetic
Figure 5. Amplification of different isoforms of Dync1i2 Exon 1b in mouse tissues using one primer pair. Isoforms of Dync1i2 Exon 1b
were amplified in mouse tissues using primer pair DIC2_Ex 1b for and DIC2_R rev which produce five products: Dync1i2.D (581 bp), Dync1i2.E
(566 bp), Dync1i2.A (531 bp), Dync1i2.B (513 bp) and Dync1i2.C (453 bp). Dync1i2.D (581 bp) is not resolved from Dync1i2.E (566 bp) due to the similar
length of PCR products; therefore we undertook nested PCRs with primers DIC2_Ex 1b for and DIC2_2.1 rev to determine the transcription pattern of
these two isoforms (data not shown). We did not detect 2(1b).F in this assay. A. Adult tissues: brain, ovary, testis and liver. In brain five amplicons are
detected as shown (and confirmed by nested PCRs). In ovary, testis and liver we detect isoform Dync1i2.C only. B. Adult neuronal tissues: In spinal
cord, cortex, hippocampus, cerebellum, brainstem and olfactory bulb five amplicons are detected as shown. C. Embryonic tissues: Three or five
amplicons are detected as shown.
doi:10.1371/journal.pone.0011682.g005
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studies have shown that neurons are particularly dependent on the
efficient function of cytoplasmic dynein. Consistent with this we
have further shown that in the mouse the expression pattern of
intermediate chain alternative splicing is richest (or more complex)
in neural tissue. This work has important implications for the
regulation of cytoplasmic dynein in neurons and will allow
additional experiments to further probe the mechanisms of
neuronal dynein regulation.
Figure 6. Examples of Dync1i2 Exon 1a isoform specific PCR. Four isoforms of Dync1i2 Exon1a are amplified in the mouse nervous system and
E17.5 embryonic nervous tissues using primer pair DIC2_Ex1a for and DIC2_6 rev. Amplicons are as shown and in addition while Dync1i2(1a).D was
not resolved in this amplification it was amplified as shown in Table 5 using primers DIC2_Ex 1a for and DIC2_2.1 rev (data not shown). We were
unable to resolve, even by nested PCR, which of isoforms Dync1i2(1a).D and Dync1i2(1a).E were present in olfactory bulb. ‘+’ lanes are cDNA, ‘2’ lanes
control for genomic DNA contamination and have no reverse transcriptase.
doi:10.1371/journal.pone.0011682.g006
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Materials and Methods
Mouse tissues
All tissues were collected from C57BL/6J inbred mice, supplied
by Harlan Laboratories. Mice were housed in controlled
conditions in accordance with guidance issued by the Medical
Research Council in Responsibility in the Use of Animals for Medical
Research (1993) and all experiments were carried out under Licence
from the UK Home Office and with full ethical approval from the
MRC Prion Unit Local Ethical Review Panel.
For RNA extraction tissues were collected from 2 male and 2
female mice aged 6–8 weeks (brain, spinal cord, ovary, testis,
Table 5. Summary of mouse dynein intermediate gene 2 splice isoform expression in different mouse tissues.
Dync1i2 Exon 1a
Tissue Dync1i2.D Dync1i2.E Dync1i2.A Dync1i2.B Dync1i2.C Dync1i2.F
Whole adult brain + + + + +
Adult spinal cord + + + + +
Adult cortex + + + + +
Adult cerebellum + + + +
Adult brainstem + + + + +
Adult hippocampus + + + +
Adult olfactory bulb + + +
Whole embryo E17.5 + + +
Embryonic brain E17.5 + + + + +
Embryonic spinal cord E17.5 + + + + +
Ovary +
Testis +
Spleen +
Kidney +
Lung +
Heart +
Intestine +
Muscle +
Liver +
Dync1i2 Exon 1b
Tissue Dync1i2.D Dync1i2.E Dync1i2.A Dync1i2.B Dync1i2.C
Whole adult brain + + + + +
Adult spinal cord + + + + +
Adult cortex + + + +
Adult cerebellum + + + + +
Adult brainstem + + + + +
Adult hippocampus + + + + +
Adult olfactory bulb + + + + +
Whole embryo E17.5 + + + +
Embryonic brain E17.5 + + + +
Embryonic spinal cord E17.5 + + + +
Ovary +
Testis +
Spleen +
Kidney +
Lung +
Heart +
Intestine +
Muscle +
Liver +
No differences were detected in male and female samples, thus results are not broken down by sex.
doi:10.1371/journal.pone.0011682.t005
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spleen, lung, kidney, heart, intestine, muscle, liver). Brain was also
collected from 2 male and 2 female mice aged 6–8 weeks and was
dissected into cortex, hippocampus, cerebellum, brainstem,
olfactory bulb. Immediately after dissection tissues were placed
in RNAse free 1.5ml tubes (Biopur, Eppendorf) and immersed in
RNAlater reagent (Qiagen) to minimize RNA degradation.
Tissues were stored at 4uC overnight and transferred to 280uC
for long term storage.
For RNA extraction from embryonic tissues, timed matings
were set up by placing a male overnight with females and
removing the male the following day. Embryos were collected
from terminally anaesthetized pregnant females at E17, and 2
whole embryos and 2 embryonic brain and spinal cords were
collected for this study as above.
RNA preparation
Tissues were weighed and RNA Mini Kits (Qiagen) were used
to extract total RNA from mouse tissues according to manufac-
turer’s instructions, in RNAse-free conditions.
Preparation of muscle and liver RNA
We found muscle and liver gave poor quality preparations,
possibly owing to either the fibrous nature of these tissues or high
lipid content in liver, therefore we modified the RNA preparation
for these tissues by homogenizing them in TRIreagent (Sigma) at
1ml per 30 mg tissue. Homogenates were centrifuged at 4uC for
30 min at 5,0006g, and supernatant was transferred to a fresh
tube for treatment with RNAse free Mussel Glygogen (Sigma) for
5 min at a final concentration of 250 ug/ml, room temperature,
after which 0.1 ml bromo-chloro-propane (BCP, Sigma) per 1 ml
of TRIreagent was added, the mixture was shaken vigorously and
incubated for 2–3 min at room temperature. After centrifugation
at 4uC for 30 min at 5,0006g the lysate separated into into 3
phases. The upper aqueous phase was carefully transferred to a
fresh tube and 0.3 ml isopropanol and 0.2 ml high salt solution
(0.8M sodium citrate, 1.2M sodium chloride) per 1 ml of
TRIreagent were added, followed by incubation for 10 min at
room temperature. After centrifugation (4uC for 30 min at
5,0006g) RNA precipitated at the bottom of the tube and was
washed with 75% ethanol (VWR), volume equal to TRIreagent,
and centrifuged (4uC for 30 min at 5,0006g). Supernatant was
removed and 1ml 75% ethanol was added. The 75% ethanol plus
pellet were transferred to an RNAse free 1.5ml tube (Biopur,
Eppendorf), centrifuged at room temperature at 14,0006g for
5 min and the supernatant carefully removed. The RNA pellet
was air dried and resuspended in 30 ul RNAse free water.
Subsequently total RNA was purified with DNAse digest using an
RNeasy Mini Kit (Qiagen) according to manufacturer’s instruc-
tions in RNAse-free conditions.
RNA quantification
Quantity and purity of RNA were determined using a
NanoDropH ND-1000 Spectrophotometer (Labtech) by measuring
absorbance at 260 nm and 280 nm (OD260, OD280). The
instrument was blanked against water and UV measurements of
1.4 ul RNA samples were taken and the OD260/280 ratio and RNA
concentrations (OD260 of 1.0 = 40 ug/ml RNA) were automati-
cally computed using the NanoDropH software. RNA purity was
assessed by OD260/280 ratio, with acceptable values lying above
1.9.
Formaldehyde agarose gel electrophoresis
RNA quality was checked by formaldehyde agarose gel
electrophoresis; 1.2% agarose gel was prepared by mixing 10 ml
106FA buffer (200 mM MOPS, 50 mM sodium acetate, 10 mM
EDTA, pH 7.0) with 90 ml RNAse free water. Agarose was
microwaved at high power for 1–2 min, cooled to 60uC and
1.8 ml 37% formaldehyde was added before pouring into gel cast
tray. RNA samples and RNA Ladder (Sigma-Aldrich) were mixed
with 26 concentrated RNA Loading Buffer containing ethidium
bromide (Sigma-Aldrich) and incubated at 65uC for 5 min to
denature possible secondary structures and rapidly chilled on ice.
Samples were loaded and electrophoresed in 16 FA running
buffer (100 ml 106FA buffer, 20 ml 37% formaldehyde, 880 ml
H2O) at 7 V/cm. Post-electrophoresis, gels were visualized and
imaged on a UV transilluminator and digital imaging system
(BioRad Laboratories).
cDNA preparation
A master mix containing 400 ng total RNA, 25 ng/ul oligo dT
primer, 4mM dNTPs and AccuScript buffer (Stratagene) to 17 ul
was incubated at 65uC for 5 min and cooled to room temperature
for 10 mins to allow primer annealing; DTT was added to 10mM
and AccuScript Reverse Transcriptase (Stratagene) was added
according to the manufacturer’s protocol to a final volume of
20 ul; negative control reactions were also prepared where the
addition of reverse transcriptase was omitted. The reaction mix
was incubated at 42uC for 45 min to produce cDNA. Aliquots
were diluted 1:10 for long term storage.
Reverse transcription - Polymerase Chain Reaction
(RT-PCR)
All the reactions were performed on a DNA Engine Tetrad 2
Peltier Thermal Cycler (BioRad Laboratories). A list of primers
used in different applications is described in Table S2. PCRs
were set up with 10 times diluted cDNAs prepared as described
Figure 7. Differential expression of Dync1i2 with exon 1a and
exon1b containing isoforms. Brain cDNA was amplified by nested
RT-PCR with exon 1a primers DIC2_Ex 1a for and DIC2_2.1 rev which
amplify 2(1a).D (315bp) and 2(1a).E (300bp), and with exon 1b primers
DIC2_Ex 1b for and DIC2_2.1 rev which amplify 2(1b).D (340bp) and
2(1b).E (325bp). We detect Dync1i2.E containing exons 1a or 1b; we
detect Dync1i2.D containing exon 1b only and not exon 1a, showing
differential expression of this isoform depending on which first non-
coding exon is spliced in the adult brain. E17.5 whole embryo cDNA was
amplified the same primer pairs (DIC2_Ex1a and DIC2_2.1 rev, and
DIC2_Ex 1b and DIC2_2.1rev). We detect no Dync1i2.D isoforms.
However, we detect 2(1b).E but not 2(1a).E, showing differential
expression of Dync1i2.E depending on which first non-coding exon is
spliced in.
doi:10.1371/journal.pone.0011682.g007
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above, the amount of cDNA was normalized to the ng of RNA
used in Reverse Transcriptase reaction. Conditions used were
annealing temperature of 58uC for 30s, and elongation at 68uC
for 3 minutes over 35 cycles using Pfu High Fidelity Polymerase
(Stratagene) according to manufacturer’s instructions. For
multiplex reactions a Multiplex PCR Kit (Qiagen) was used
according to manufacturer’s instructions with an annealing
temperature of 60uC for 90 sec, elongation at 72uC for 1 min
Figure 8. Exon – protein domain relationship for dynein intermediate chain genes. Protein domains marked as blocks, numbered exons
marked in grey. The coiled coil region where protein interactions occur is shown as is DYNLT – binding region of Tctex dynein light chains, DYNLL –
binding region of LC8 dynein light chains, DIM – intermediate chain dimerisation domain, DYNLRB – binding domain of Roadblock dynein light
chains; seven WD40 repeats marked in green. The domain boundaries are as shown in Table S3 [19,8,20,39,40,24,41]. A. Mouse DYNC1I1 isoform 1.A
(645 amino acids). B. Mouse DYNC1I2 isoform 2.D (655 amino acids). Note that isoform 2.D includes exons 1 to 3 and new exon 3b; exon 4 to 18. C.
Schematic alignment of DYNC1I1 and DYNC1I2 protein sequences coded by exons 3 to 6 of Dync1i1 and exons 3 to 7 of Dync1i2 genes; alternative
splice sites in Dync1i1 exon 4 (AS1, AS2, AS3) and Dync1i2 exon 3b (AS1, AS2) are marked. The percent of identity (ID) and similarity (Sim) between
segments of protein sequences coded by specific exons were compared using AliSubSimP. Protein sequences of DYNC1I1 and DYNC1I2 encoded by
exons 3 are 51.2% identical and 73.2% similar; protein sequence of DYNC1I1 exon 4 was compared as two segments marked with asterix: 4* from AS1
to AS2 and 4** from AS2 to the end of exon 4. There is only 8.7% identity and 21.7% similarity between Dync1i1 exon 4* and DYNC1I2 exons 3b and 4
while DYNC1I1 exon 4** and DYNC1I2 exon 5 show 77.4% identity and 83.9% similarity. Furthermore, DYNC1I1 exon 5 is 85.0% identical and 90.0%
similar to DYNC1I2 exon 6. Protein sequences of DYNC1I1 encoded by exon 6 and DYNC1I2 encoded by exon 7 are 57.9% identical and 76.3% similar.
The whole fragments of the intermediate chains presented show 56.3% identity and 71.5% similarity. D. Alignment of DYNC1I1 and DYNC1I2 protein
sequences encoded by exons 3 to 6 of Dync1i1 and exons 3 to 7 of Dync1i2 genes; alternative splice sites in Dync1i1 exon 4 (AS1, AS2, AS3) and in
Dync1i2 exon 3b (AS1, AS2) marked, amino acids shaded overlap splice sites.
doi:10.1371/journal.pone.0011682.g008
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over 35 cycles. PCR products were purified using QIAquick PCR
purification kits (Qiagen) according to manufacturer’s instruc-
tions. PCR products were visualized by electrophoresis on
agarose gels in 16TBE buffer (National Diagnostics) according
to standard protocols. The quality of cDNA obtained was
checked by amplifying a 780bp product from the mouse Gapdh
gene which is ubiquitously expressed (Figure S3).
Subcloning cDNAs
After amplification PCR products were subcloned into the
pCR4-TOPOH vector (Invitrogen) using a TOPO TA kit
(Invitrogen) according to manufacturer’s instructions.
Sequencing
Automated fluorescence sequencing was carried out with a
BigDye Terminator Ready Reaction Kit (Applied Biosystems) on a
3130XL Genetic Analyser (Applied Biosystems) according to
manufacturer’s protocols.
Bioinformatics analysis
We searched the UCSC Genome Browser which is developed
and maintained by the Genome Bioinformatics Group within the
Center for Biomolecular Science and Engineering at the
University of California Santa Cruz (UCSC); the 2009 update
describes 46 genome assemblies for including those for human
(assembly hg19, October 2009), mouse (assembly mm9, July
2007), rat (assembly rn4, November 2004, EST database update
October 2008), with extensive comparative genomics tools (Kuhn
et al. 2009). Transcripts assigned as permanent have an ‘uc’
accession number. The mouse transcripts of Dync1i1 and Dync1i2
were also compared with entries found in the Ensembl Genome
Browser release 57 (3 March 2010). ESTs mentioned in the text
were those which extend from exon 1 sufficiently far into the
cDNA (Dync1i1 or Dync1i2) to determine which isoform they
represented.
We used several tracks within the UCSC Genome Browser to
help identify possible splice variants in mouse including:
UCSC ‘Known Genes’. All UCSC Gene tracks show gene
predictions based on data from RefSeq (NCBI RNA reference
sequences), GenBank, CCDS (Consensus Coding DNA Sequences)
and UniProt, thus they are a moderately conservative set of
predictions, requiring the support of one GenBank RNA sequence
plus at least one additional line of evidence (e.g. a UniProt,
‘Exoniphy’ prediction, or two or more expressed sequence tags
(ESTs)). The RefSeq RNAs do not require additional evidence.
Thus tracks include both protein-coding and putative non-coding
transcripts, and compared to RefSeq genes contain more splice
variants.
Database of Transcription Start Sites. DBTSS (http://
dbtss.hgc.jp/, release 6.0.1) is a database of transcriptional start
sites (TSS), based on an unique collection of precise,
experimentally-determined 59-end sequences of full-length
cDNAs [26]. The use of an oligo-capping technique allows TSS
to be assigned to independent genomic positions to which the first
bases of sequenced cDNA were mapped, thus most cDNA
sequence 59 ends should correspond to active TSSs [43].
Transcription Factor Binding Sites. The HMR (Human,
Mouse, Rat) conserved transcription factor binding sites track in
the UCSC Genome Browser contains the location and score of
transcription factor binding sites conserved in the human/mouse/
rat alignment. A binding site is considered to be conserved if its
score meets the threshold score for its binding matrix in all 3
species. The score and threshold are computed with the Transfac
Matrix Database (v7.0) created by Biobase (http://www.gene-
regulation.com/pub/databases.html). The data are purely
computational, and as such not all binding sites listed are
biologically functional. The analysis presented here was only
undertaken for sites upstream to the transcription start (exon 1) for
both Dync1i1 and Dync1i2.
Target Scan. The Target Scan miRNA regulatory sites track
of the UCSC Genome Browser shows conserved mammalian
microRNA regulatory target sites in the 39 UTR regions of Refseq
Genes, as predicted by TargetScan [44]. Putative miRNA binding
sites in UTRs were identified using seven-nucleotide seed regions
from all known miRNA families conserved among human, mouse,
rat, dog and sometimes chicken [45].
Protein sequence analysis. Protein sequences were aligned
using ClustalW2 (http://srs.ebi.ac.uk) with Gonnet set as a
substitution matrix. Subsequently they were compared using
AliSubSimP (http://srs.ebi.ac.uk) with EBLOSUM62 as a scoring
matrix.
Supporting Information
Figure S1 Example of amplifying Dync1i1.C in non-neuronal
mouse tissues. Primers DIC1 Ex1 for and DIC1_R rev amplify all
six Dync1i1 isoforms (see Figure 2), however in non-neuronal
tissues we detect isoform Dync1i1.C only (420bp) in ovary and
testis. ‘+’ lanes are cDNA, ‘2’ lanes control for genomic DNA
contamination and have no reverse transcriptase.
Found at: doi:10.1371/journal.pone.0011682.s001 (0.86 MB TIF)
Figure S2 Amplification of Dync1i1.F in mouse neuronal tissues.
Primers DIC1_1.1 for and DIC1_iso14 rev amplify a 155 bp
product from isoform 1.F. One sample in hippocampus and one in
cortex failed to amplify. ‘+’ lanes are cDNA, ‘2’ lanes control for
genomic DNA contamination and have no reverse transcriptase.
Found at: doi:10.1371/journal.pone.0011682.s002 (3.82 MB TIF)
Figure S3 Example of Gapdh amplicon in mouse tissues. Gapdh is
ubiquitously expressed and a single band of 780 bp was visualised
in ‘reverse transcriptase positive’ samples while no bands were
visible in samples in which no reverse transcriptase had been
added. This was our control for cDNA quality.
Found at: doi:10.1371/journal.pone.0011682.s003 (2.47 MB TIF)
Table S1 Exon intron boundaries of mouse Dync1i1 and Dync1i2.
Found at: doi:10.1371/journal.pone.0011682.s004 (0.02 MB
DOCX)
Table S2 Primer sequences used to determine the splicing
pattern of Dync1i1 and Dync1i2.
Found at: doi:10.1371/journal.pone.0011682.s005 (0.01 MB
DOCX)
Table S3 The position of protein domains in the longest
DYNC1I1 and DYNC1I2 isoforms.
Found at: doi:10.1371/journal.pone.0011682.s006 (0.01 MB
DOCX)
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